Hear from Our Patients

Jim Keegan was diagnosed with breast cancer in 2013. Since undergoing treatment at Memorial Sloan Kettering, he has become a fierce advocate for male breast cancer awareness.

Dan Hussar was feeling fine after treatment for acute myeloid leukemia (AML). But when some unusual bumps on his skin turned out to be an AML relapse, the Philadelphia resident and pharmacy professor began to feel discouraged by his lack of options. That’s when Dan’s doctor suggested a clinical trial at Memorial Sloan Kettering. The trial was targeted to specific mutations found in Dan’s tumor, and the results seemed promising.